This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

7 Stocks Under $10 With Relative Strength

Transition Therapeutics

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Transition Therapeutics (TTHI) is a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets. This stock is trading up 6% at $2.25 in recent trading.

Today's Range: $2.12-$2.25

52-Week Range: $1.15-$3.00

Volume: 5,916

Three-Month Average Volume: 19,118

>>22 Biopharma Stocks With Breakout Potential

From a technical perspective, TTHI is jumping to the upside here with light volume. This move has pushed the stock into near-term breakout territory, since TTHI has taken out some resistance at $2.16. Traders should now look to play the next major breakout trade for TTHI. That trade will trigger once TTHI takes out some near-term overhead resistance at $2.35 with high-volume.

Traders should look for long-biased trades once TTHI sustains a move or close over $2.35 with volume that's near or above 19,118 shares. If that breakout triggers soon, then TTHI has an excellent chance of tagging its next major overhead resistance levels at $2.79 to $3.23 in the near future.
7 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ATRS $1.65 0.00%
CECO $3.78 0.00%
DSCO $0.33 0.00%
JMBA $14.21 0.00%
AAPL $110.38 0.00%


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs